The EIC Accelerator is the European Innovation Council’s (EIC) programme for SMEs. Launched by the European Commission in September 2019 in its pilot phase ahead of Horizon Europe. The EIC aims to stimulate Europe’s economic growth by enabling visionary and … Read More
HOME
THE FIRST LINE OF VERSATILE, PERSONALISED
ANTIMICROBIAL, ANTIVIRAL
AND ANTI-INFLAMMATORY COATINGS
FOR MEDICAL DEVICES
FOR DAILY USE*
*Shown to inactivate SARS-CoV-2 (Covid-19)
Hospital-acquired infection
0
%
of cases related with medical devices
Diabetic foot ulcers
0
%
infection rate
Antibiotic resistant bacteria
0
K
deaths in Europe each year
Antibiotic resistance
0
M
deaths expected worldwide by 2050
SPARTHA Medical has developed multifunctional coatings specially formulated to prevent infection and bacterial resistance.
We offer customised coating development for producers with specific properties optimized for the target microenvironment
We develop a « coating kit » to be utilized directly in hospitals with respect to the patient immunoprofile
We develop a biocompatible spray for general/daily use
OUR STORY
SPARTHA Medical is a spin-off from INSERM UMR1121
a public research institute with more than 20 years of experience in development of coating.
SPARTHA Medical’s core technologies are based patented inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
OUR TEAM
Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
OUR SUPPORTS
SPARTHA Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM and our partners in the ongoing | PANBioRa project.
We are incubated in | SEMIA and financially supported by | Grand Est region (Start-up support) and | French Public Bank of Investment (BPI, i-Lab 2019)
PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION
TAKE A LOOK AT OUR LATEST NEWS
SPARTHA Medical raised €1.4M
SPARTHA MEDICAL COMPLETES ITS FIRST ROUND OF FUNDING TO DEVELOP ITS CUSTOMISED COATINGS OFFER (€1.4M) Strasbourg, FRANCE, 8 Decembre 2021. SPARTHA Medical, a French MedTech company specialising in the development of multifunctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to … Read More
Research and development approval (CIR)
SPARTHA Medical has been granted for CIR accreditation SPARTHA Medical is pleased to announce the company has been granted for CIR accreditation for research and development (R&D) after scientific and technical expertise. • What does it mean ? The Research Tax Credit … Read More